Income Statement

v3.10.0.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
REVENUES        
Real property rental $ 272,444 $ 315,284 $ 847,939 $ 537,538
Medical related consulting services - related parties 71,398 2,166 213,394 220,949
Development services and sales of developed products 69,661 156,176
Total Revenues 413,503 317,450 1,217,509 758,487
COSTS AND EXPENSES        
Real property operating expenses 190,899 180,722 597,114 342,576
Medical related consulting services - related parties 64,196 47,033 188,911 271,845
Development services and sales of developed products 40,386 98,999
Total Costs and Expenses 295,481 227,755 885,024 614,421
REAL PROPERTY OPERATING INCOME 81,545 134,562 250,825 194,962
GROSS PROFIT (LOSS) FROM MEDICAL RELATED CONSULTING SERVICES 7,202 (44,867) 24,483 (50,896)
GROSS PROFIT FROM DEVELOPMENT SERVICES AND SALES OF DEVELOPED PRODUCTS 29,275 57,177
OTHER OPERATING EXPENSES:        
Selling expense 148 15,138
Advertising expenses 150,548 150,548
Compensation and related benefits 569,915 468,837 1,596,181 857,237
Professional fees 1,449,768 186,208 2,614,565 566,131
Other general and administrative 327,209 92,421 878,582 245,080
Total Other Operating Expenses 2,497,440 747,614 5,239,876 1,683,586
LOSS FROM OPERATIONS (2,379,418) (657,919) (4,907,391) (1,539,520)
OTHER INCOME (EXPENSE)        
Interest income 1,394 122 3,102 1,126
Interest expense (25,205) (52,932) (287,123) (94,932)
Foreign currency transaction loss (106,929) (57,244)
Other (expense) income (22) 306
Total Other Expense, net (23,833) (52,810) (390,644) (151,050)
LOSS BEFORE INCOME TAXES (2,403,251) (710,729) (5,298,035) (1,690,570)
INCOME TAXES
NET LOSS (2,403,251) (710,729) (5,298,035) (1,690,570)
LESS: NET LOSS ATTRIBUTABLE TO NON-CONTROLLING INTEREST (58,581) (177,392)
NET LOSS ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS (2,344,670) (710,729) (5,120,643) (1,690,570)
COMPREHENSIVE LOSS        
NET LOSS (2,403,251) (710,729) (5,298,035) (1,690,570)
Unrealized foreign currency translation (loss) gain (94,069) 6,151 (137,438) (25,973)
COMPREHENSIVE LOSS (2,497,320) (704,578) (5,435,473) (1,716,543)
LESS: COMPREHENSIVE LOSS ATTRIBUTABLE TO NON-CONTROLLING INTEREST (58,794) (177,564)
COMPREHENSIVE LOSS ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS $ (2,438,526) $ (704,578) $ (5,257,909) $ (1,716,543)
NET LOSS PER COMMON SHARE ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS        
Basic and diluted $ (0.03) $ (0.01) $ (0.07) $ (0.03)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:        
Basic and diluted 72,573,462 64,628,622 71,611,375 63,958,292

Source